医療法人社団 順清会 Total Cell Clinic TOKYO
Explore the institution's name, address and registered technologies as published, along with plan classifications, score components and sources.
The ranking reflects only the registration data published by Japan's Ministry of Health, Labour and Welfare; it does not represent treatment outcomes or quality of care. Scoring method →
Source: Ministry of Health, Labour and Welfare public directory of regenerative medicine providers MHLW e-Regenerative Medicine public register · Directory archive date I: 2026-07-19 / II: 2026-09-26 / III: 2026-05-18 · Internet Archive
02C2406066 +4Location
- Prefecture
- Tokyo
- Address
- 港区海岸1-16-1 ニューピア竹芝サウスタワー13階
Plan classification
- Class INot registered
- Class IIThe medium-risk category under the law.
- Class IIIThe low-risk category under the law.
Certified committee for regenerative medicine
- 安全未来特定認定再生医療等委員会
- 日本肌再生医学会特定認定再生医療等委員会
- 日本肌再生医学会認定再生医療等委員会
Public score
59.5/ 100
- A · Review level
- 25.0 / 30
- B · Technologies
- 20.6 / 35
- C · Coverage
- 7.1 / 25
- D · Class I / II technologies
- 6.7 / 10
The public score is calculated from public registration information and does not reflect quality of care. Scoring method →
Registered technologies (5)
Stem cells (all sources) 4
| Registered technologies · Japanese original | Technology areas | Plan classification |
|---|---|---|
| 自己脂肪由来間葉系幹細胞を用いた変形性関節症治療 | Stem cells (all sources)Adipose-derived stem cellsJoints and musculoskeletal | Class II |
| 慢性疼痛に対する自己脂肪由来間葉系幹細胞による治療 | Stem cells (all sources)Adipose-derived stem cells | Class II |
| 自己脂肪由来間葉系幹細胞による糖尿病又は境界型糖尿病の治療 | Stem cells (all sources)Adipose-derived stem cells | Class II |
| 自己脂肪由来間葉系幹細胞を用いた変形性膝関節症の治療 | Stem cells (all sources)Adipose-derived stem cellsJoints and musculoskeletal | Class II |
Adipose-derived stem cells 4
| Registered technologies · Japanese original | Technology areas | Plan classification |
|---|---|---|
| 自己脂肪由来間葉系幹細胞を用いた変形性関節症治療 | Stem cells (all sources)Adipose-derived stem cellsJoints and musculoskeletal | Class II |
| 慢性疼痛に対する自己脂肪由来間葉系幹細胞による治療 | Stem cells (all sources)Adipose-derived stem cells | Class II |
| 自己脂肪由来間葉系幹細胞による糖尿病又は境界型糖尿病の治療 | Stem cells (all sources)Adipose-derived stem cells | Class II |
| 自己脂肪由来間葉系幹細胞を用いた変形性膝関節症の治療 | Stem cells (all sources)Adipose-derived stem cellsJoints and musculoskeletal | Class II |
Joints and musculoskeletal 2
| Registered technologies · Japanese original | Technology areas | Plan classification |
|---|---|---|
| 自己脂肪由来間葉系幹細胞を用いた変形性関節症治療 | Stem cells (all sources)Adipose-derived stem cellsJoints and musculoskeletal | Class II |
| 自己脂肪由来間葉系幹細胞を用いた変形性膝関節症の治療 | Stem cells (all sources)Adipose-derived stem cellsJoints and musculoskeletal | Class II |
Other 1
| Registered technologies · Japanese original | Technology areas | Plan classification |
|---|---|---|
| AKC(Autologous Killer Cell)免疫療法(免疫力の改善) | Other | Class III |
Certified committee for regenerative medicine
- 安全未来特定認定再生医療等委員会
- 日本肌再生医学会特定認定再生医療等委員会
- 日本肌再生医学会認定再生医療等委員会
Public document number
02C240606602C240700102C240700202C220203402C2407003
Plan classification · Certified committee for regenerative medicine · Public document number
| Registered technologies | Plan classification | Certified committee for regenerative medicine | Public document number |
|---|---|---|---|
| 慢性疼痛に対する自己脂肪由来間葉系幹細胞による治療 | Class II | 安全未来特定認定再生医療等委員会 | 02C2406066 |
| 自己脂肪由来間葉系幹細胞による糖尿病又は境界型糖尿病の治療 | Class II | 日本肌再生医学会特定認定再生医療等委員会 | 02C2407001 |
| 自己脂肪由来間葉系幹細胞を用いた変形性膝関節症の治療 | Class II | 日本肌再生医学会特定認定再生医療等委員会 | 02C2407002 |
| AKC(Autologous Killer Cell)免疫療法(免疫力の改善) | Class III | 日本肌再生医学会認定再生医療等委員会 | 02C2202034 |
| 自己脂肪由来間葉系幹細胞を用いた変形性関節症治療 | Class II | 安全未来特定認定再生医療等委員会 | 02C2407003 |
Other institutions in the same prefecture
- 医療法人社団 形成会 酒井形成外科Public score 59.5
- 医療法人社団禅 銀座プラタナクリニックPublic score 59.8
- 幹細胞クリニック東京Public score 59.8
- 医療法人社団 東雲会 新橋虎ノ門健康クリニックPublic score 59.1
- AR-Ex尾山台整形外科Public score 60.0
- 医療法人社団 銀緑会 よしき銀座クリニックPublic score 60.0
- 一般社団法人SERENDIPITY Clinic KPublic score 60.0
- 銀座よしえクリニック銀座院Public score 60.0